α-Catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling

Nature Cell Biology

Volumn 16, Issue 3, 2014, Pages 245-254

  Piao, Hai Long ^a   Yuan, Yuan ^a,b   Wang, Min ^a   Sun, Yutong ^a   Liang, Han ^a   Ma, Li ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEASOME; PROTEIN P50; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CTNNA1 GENE; DOWN REGULATION; E CADHERIN NEGATIVE BASAL LIKE BREAST CANCER; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UBIQUITINATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ALPHA CATENIN; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; I-KAPPA B PROTEINS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASMS, BASAL CELL; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 84895440197     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2909     Document Type: Article

References (46)

1. Di Cosimo, S. & Baselga, J. Management of breast cancer with targeted agents: importance of heterogeneity. [corrected]. Nat. Rev. Clin. Oncol. 7, 139-147 (2010).
2. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
3. Sorlie, T. et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA 100, 8418-8423 (2003).
4. Prat, A. & Perou, C. M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 5, 5-23 (2011).
5. Rakha, E. A., El-Sayed, M. E., Reis-Filho, J. & Ellis, I. O. Patho-biological aspects of basal-like breast cancer. Breast Cancer Res. Treat. 113, 411-422 (2009).
6. Perou, C. M. Molecular stratification of triple-negative breast cancers. Oncologist 16 (Suppl 1), 61-70 (2011).
7. Osborne, C. K. Tamoxifen in the treatment of breast cancer. New Engl. J. Med. 339, 1609-1618 (1998).
8. Slamon, D. J. et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712 (1989).
9. Kobielak, A. & Fuchs, E. catenin: at the junction of intercellular adhesion and actin dynamics. Nat. Rev. Mol. Cell Biol. 5, 614-625 (2004).
10. The Cancer Genome Atlas Network, Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
11. Onder, T. T. et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645-3654 (2008).
12. Derksen, P. W. et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10, 437-449 (2006).
13. Fodde, R. & Brabletz, T. Wnt/β-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol. 19, 150-158 (2007).
14. Liu, T. X. et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding α-catenin (CTNNA1) in myeloid cell transformation. Nat. Med. 13, 78-83 (2007).
15. Ji, H., Wang, J., Fang, B., Fang, X. & Lu, Z. α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation. J. Neurooncol. 103, 445-451 (2011).
16. Schlegelmilch, K. et al. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 144, 782-795 (2011).
17. Silvis, M. R. et al. α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci. Signal. 4, ra33 (2011).
18. Bajpai, S., Feng, Y., Krishnamurthy, R., Longmore, G. D. & Wirtz, D. Loss of α-catenin decreases the strength of single E-cadherin bonds between human cancer cells. J. Biol. Chem. 284, 18252-18259 (2009).
19. Yamaguchi, N. et al. Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines. Cancer Sci. 100, 1668-1674 (2009).
20. Baud, V. & Karin, M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 8, 33-40 (2009).
21. Pahl, H. L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866 (1999).
22. Hayden, M. S. & Ghosh, S. Signaling to NF-κB. Genes Dev. 18, 2195-2224 (2004).
23. Baltimore, D. Discovering NF-κB. Cold Spring Harb. Perspect. Biol. 1, a000026 (2009).
24. Karin, M., Yamamoto, Y. & Wang, Q. M. The IKK NF-κB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3, 17-26 (2004).
25. Basseres, D. S. & Baldwin, A. S. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 25, 6817-6830 (2006).
26. Hollestelle, A. et al. Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations. Breast Cancer Res. Treat. 122, 125-133 (2010).
27. Collart, M. A., Baeuerle, P. & Vassalli, P. Regulation of tumor necrosis factor α transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell Biol. 10, 1498-1506 (1990).
28. Kunsch, C. & Rosen, C. A. NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol. Cell Biol. 13, 6137-6146 (1993).
29. Vincenti, M. P., Coon, C. I. & Brinckerhoff, C. E. Nuclear factor κB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1β- stimulated synovial fibroblasts. Arthritis Rheum. 41, 1987-1994 (1998).
30. Matluk, N., Rochira, J. A., Karaczyn, A., Adams, T. & Verdi, J. M. A role for NRAGE in NF-κB activation through the non-canonical BMP pathway. BMC Biol. 8, 7 (2010).
31. Lien, W. H., Gelfand, V. I. & Vasioukhin, V. α-E-catenin binds to dynamitin and regulates dynactin-mediated intracellular traffic. J. Cell Biol. 183, 989-997 (2008).
32. Pickart, C. M. & Fushman, D. Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol. 8, 610-616 (2004).
33. Bren, G. D. et al. Transcription of the RelB gene is regulated by NF-κB. Oncogene 20, 7722-7733 (2001).
34. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010).
35. Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005 (2010).
36. Kobielak, A. & Fuchs, E. Links between catenin, NF-κB, and squamous cell carcinoma in skin. Proc. Natl Acad. Sci. USA 103, 2322-2327 (2006).
37. Hu, Y. et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284, 316-320 (1999).
38. Yan, J. et al. Inactivation of BAD by IKK inhibits TNFα-induced apoptosis independently of NF-κB activation. Cell 152, 304-315 (2013).
39. Ben-Neriah, Y. & Karin, M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715-723 (2011).
40. Gilmore, T. D. Introduction to NF-κB: players, pathways, perspectives. Oncogene 25, 6680-6684 (2006).
41. Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2, 301-310 (2002).
42. Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R. J. & Sonenshein, G. E. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN. Oncogene 20, 1287-1299 (2001).
43. Elenbaas, B. et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65 (2001).
44. Stewart, S. A. et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493-501 (2003).
45. Yang, W. L. et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134-1138 (2009).
46. Wang, W. et al. PTPN14 is required for the density-dependent control of YAP1. Genes Dev. 26, 1959-1971 (2012).